EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling

Jude Tetteh Quarshie iD, Kwadwo Fosu iD, Nicholas Awuku Offei iD, Augustine Kojo Sobo, Osbourne Quaye iD, Anastasia Rosebud Aikins iD

Pharmaceuticals · 19.07.2023 · 16 (7) · 1026

DOI: 10.3390/ph16071026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.07.2023. Verfasst von Jude Tetteh Quarshie und 5 weiteren Autor:innen. Beteiligte Einrichtung: West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Department of Biochemistry Cell and Molecular Biology, University of Ghana, A…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Bank African Centres of Excellence grant (WACCBIP+NCDs: Awandare), DELTAS Africa grant (DEL-15-007: Awandare) and Wellcome Trust [DEL-15-007]., World Bank African Centres of Excellence, DELTAS Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the third most frequent cancer and the second leading cause of cancer-related deaths globally. Evidence shows that over 90% of CRC cases are initiated by a deregulated Wingless Integrated Type-1 (WNT)/β-catenin signaling pathway. The WNT/β-catenin pathway also promotes CRC cell proliferation, stemness, and metastasis. Therefore, modulators of the WNT/β-catenin pathway may serve as promising regimens for CRC. This study investigated the effect of cryptolepine—a plant-derived compound—on the WNT/β-catenin pathway in CRC. Two CRC cell lines, COLO205 and DLD1, were treated with cryptolepine or XAV 939 (a WNT inhibitor) in the presence or absence of WNT3a (a WNT activator). Using a tetrazolium-based assay, cryptolepine was found to reduce cell viability in a dose- and time-dependent manner and was a more potent inhibitor of viability than XAV 939. RT-qPCR analyses showed that cryptolepine reverses WNT3a-induced expression of β-catenin, c-MYC, and WISP1, suggesting that cryptolepine inhibits WNT3a-mediated activation of WNT/β-catenin signaling. Cryptolepine also repressed WNT3a-induced OCT4 and CD133 expression and suppressed colony formation of the cells, indicating that cryptolepine inhibits the stemness of CRC cells. Additionally, cryptolepine inhibited WNT3a-induced epithelial-to-mesenchymal transition by reducing the expression of SNAI1 and TWIST1 genes. In a wound healing assay, cryptolepine was found to suppress cell migration under unstimulated and WNT3a-stimulated conditions. Moreover, cryptolepine downregulated WNT3a-induced expression of MMP2 and MMP9 genes, which are involved in cancer cell invasion. Altogether, cryptolepine suppresses CRC cell proliferation, stemness, and metastatic properties by inhibiting WNT3a-mediated activation of the WNT/β-catenin signaling pathway. These findings provide a rationale for considering cryptolepine as a potential WNT inhibitor in CRC.

Schlagwörter

Stichwörter der Autor:innen

WNT/β-catenin signalingcolorectal cancercryptolepinemetastasisproliferationstemness

Autor:innen und Institutionen

  • West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Department of Biochemistry Cell and Molecular Biology, University of Ghana, Accra P.O. Box LG 54, Ghana.

ORCID-Profile: Jude Tetteh Quarshie, Kwadwo Fosu, Nicholas Awuku Offei, Osbourne Quaye, Anastasia Rosebud Aikins

Förderung

  • World Bank African Centres of Excellence grant (WACCBIP+NCDs: Awandare), DELTAS Africa grant (DEL-15-007: Awandare) and Wellcome Trust [DEL-15-007].
  • World Bank African Centres of Excellence
  • DELTAS Africa
  • Wellcome Trust
  • UK Foreign
  • Commonwealth & Development Office

Zitieren

APA

Quarshie, J. T., Fosu, K., Offei, N. A., Sobo, A. K., Quaye, O., & Aikins, A. R. (2023). Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling. Pharmaceuticals, 16(7), 1026. https://doi.org/10.3390/ph16071026

Vancouver

Quarshie JT, Fosu K, Offei NA, Sobo AK, Quaye O, Aikins AR. Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling. Pharmaceuticals. 2023;16(7):1026. doi:10.3390/ph16071026

BibTeX
@article{Quarshie2023,
  author = {Quarshie, Jude Tetteh and Fosu, Kwadwo and Offei, Nicholas Awuku and Sobo, Augustine Kojo and Quaye, Osbourne and Aikins, Anastasia Rosebud},
  title = {Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {7},
  pages = {1026},
  doi = {10.3390/ph16071026}
}
Kostenlos starten →